<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00362661</url>
  </required_header>
  <id_info>
    <org_study_id>PTSD-06</org_study_id>
    <nct_id>NCT00362661</nct_id>
  </id_info>
  <brief_title>Low-dose Cortisol in Chronic Posttraumatic Stress Disorder</brief_title>
  <official_title>Low-dose Cortisol in Chronic Posttraumatic Stress Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      The aim of this prospective, double-blind, placebo-controlled, cross-over study is to
      determine the therapeutic efficacy of low-dose cortisol for symptoms of chronic posttraumatic
      stress disorder.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment: Insufficient number of patients eligible for enrollment
  </why_stopped>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CAPS CGI</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cortisol</intervention_name>
    <description>Cortisol 10 mg/d for 3 months</description>
    <other_name>Cortisol (10 mg), Galepharm, Küsnacht, Switzerland</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female and male patients with chronic PTSD due to adult trauma; PTSD is diagnosed
             according to the DSM-IV, as measured with the CAPS

          -  Age between 18 and 60

        Exclusion Criteria:

          -  History of disease states representing contraindications to glucocorticoid therapy
             (tuberculosis, gastritis, gastric- and duodenal ulcers, Cushing's disease,
             osteoporosis, hypertension, pregnancy (to exclude with a pregnancy test) and
             lactation, glaucoma, diabetes mellitus, thrombophilia, acute or chronic infections,
             hyperthyroidism, cirrhosis)

          -  Severe or chronic somatic diseases

          -  Topic glucocorticoid therapy (for large skin parts)

          -  Inhaled glucocorticoids

          -  Current psychotic, bipolar, substance-related, or severe personality disorder

          -  Current severe depressive disorder

          -  Severe cognitive impairment or a history of organic mental disorder

          -  Evidence of PTSD or depression immediately prior to the index trauma

          -  Prominent current suicidal or homicidal ideation

          -  Asylum seeking status

          -  Body weight &gt;20% above or below normal range

          -  Changes in psychopharmacologic or psychotherapeutic management less than 8 weeks
             before start of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique de Quervain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Psychiatry Research, University of Zurich, Lenggstr. 31, 8032 Zurich, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich Schnyder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry, University Hospital Zurich, Culmannstrasse 8, 8091 Zürich, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, Nitsch RM, Schnyder U, de Quervain DJ. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry. 2004 Aug;161(8):1488-90.</citation>
    <PMID>15285979</PMID>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2006</study_first_submitted>
  <study_first_submitted_qc>August 9, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2006</study_first_posted>
  <last_update_submitted>January 11, 2010</last_update_submitted>
  <last_update_submitted_qc>January 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dominique de Quervain, Prof. MD</name_title>
    <organization>University of Zurich</organization>
  </responsible_party>
  <keyword>PTSD</keyword>
  <keyword>cortisol</keyword>
  <keyword>memory</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

